Download as pdf or txt
Download as pdf or txt
You are on page 1of 5

Navigating the intricacies of crafting a comprehensive literature review on adverse events can be a

daunting task for many. The process involves extensive research, critical analysis, and synthesis of
existing literature to provide a thorough understanding of the topic. From identifying relevant
sources to summarizing key findings and discussing their implications, every step requires precision
and attention to detail.

One of the primary challenges of writing a literature review is the sheer volume of information
available. With countless studies, articles, and reports published on adverse events across various
disciplines, sifting through the vast sea of literature can be overwhelming. Moreover, ensuring that
the selected sources are credible and up-to-date adds another layer of complexity to the process.

Another challenge lies in synthesizing the information gathered from diverse sources into a coherent
narrative. A literature review should not merely summarize individual studies but rather analyze and
integrate them to develop a comprehensive understanding of the topic. This requires critical thinking
and the ability to identify patterns, inconsistencies, and gaps in the existing literature.

Furthermore, maintaining clarity and coherence throughout the review is essential to effectively
communicate the findings to the reader. Organizing the information logically, structuring the review
according to themes or chronological order, and providing clear transitions between sections are
crucial aspects of this process.

Given the complexities involved in writing a literature review on adverse events, many individuals
may find themselves in need of assistance. ⇒ StudyHub.vip ⇔ offers a solution to this challenge by
providing professional writing services tailored to meet the specific needs of clients. With a team of
experienced writers well-versed in conducting literature reviews, ⇒ StudyHub.vip ⇔ ensures high-
quality, well-researched papers that adhere to academic standards.

By entrusting the task to ⇒ StudyHub.vip ⇔, individuals can save time and effort while ensuring
that their literature review effectively communicates their research findings and insights. Whether
you're a student struggling to meet deadlines or a researcher looking to enhance the quality of your
work, ⇒ StudyHub.vip ⇔ is here to help you succeed. Order your literature review today and
experience the difference professional assistance can make.
At the national level, social and healthcare ministries are responsible for planning, guidance and
implementation of health and social policy to safeguard people’s ability to work and function. After
an overview of similar strategic measuring tools in industry (Fitzgerald et al. Organisational “action
after AEs” infrastructure needed to have appointed personnel, clear support and learning
infrastructure and clear processes. We use cookies on our website to ensure you get the best
experience. From the literature reviewed changes appear needed at the individual, team, unit and
organisational levels. Adverse events affecting treatment administration, adherence, and quality of
life should be expressed not only in terms of severity and frequency but also in terms of duration.
This includes SUSARs associated with active comparator drugs. Decisions were not finalized until
group wide consensus was reached. Table 4 Example of table presenting confidence intervals with
adverse event data (Recommendation 3). 28 This table defines confidence intervals for the
differences between investigational and control patient groups (right hand column). Efficacy and
safety of evolocumab in reducing lipids and cardiovascular events. The Creative Commons Public
Domain Dedication waiver ( ) applies to the data made available in this article, unless otherwise
stated. Examples include the evolution of adverse event signals (as the database of recruited patients
matures or longer follow-up time accrues between publications for the same study cohort) as well as
changes in adverse events definitions or groupings, data censoring conventions, and how subgroups
of patient populations are reported (eg, age groups defined differently). Thus, communication is
fundamental to occupational and patient safety. What are the requirements of a set of key
performance indicators (KPIs) that meet. Three types of victims of patient-related adverse events can
be identified. Savignon, S (2000). Communicative language teaching. In M. Byran (ed). Routledge.
We recommend using an approach that determines the appropriateness of statistical analyses via a
tiered system that assumes that it is important to report information about all events, but that only
some events require formal hypothesis testing (box 2). 31 Box 2: Safety planning, evaluation, and
reporting team (SPERT) recommendations (Recommendation 3) The system categorizes events into
one of three categories or tiers for analysis. Ten recommendations for closing the credibility gap in
reporting industry-sponsored clinical research: a joint journal and pharmaceutical industry
perspective. The third victim theme consisted of organisational action after AEs, strategy,
infrastructure and training and open communication about AEs. In this integrative review, second
victim support programs were under development work. A randomized, double-blind, placebo-
controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in
patients with partial-onset seizures. Within power relations however, (such as between a target setter
and the worker. Additional guidance could help authors better identify, communicate, and display
clinically relevant adverse event information in ways that facilitate clinicians’ benefit-risk
assessments for shared treatment decisions with patients. Studies were limited to the two FDA-
approved vaccines. Schools are a group of organisations that have always focused on outcomes other.
What policies, guidelines, or best practices exist and how are they followed. Prophylaxis of
ThromboEmbolism in Critical Care Trials (PROTECT): a pilot study. The results suggested a need
for holistic approaches to managing AEs. Stata (version 12.0, College Station, TX, USA) and
GraphPad Software were used for statistical interpretations of the raw data. NOTE: We only request
your email address so that the person you are recommending the page to knows that you wanted
them to see it, and that it is not junk mail.
Ensuring consistency among these various channels is helpful to ensure the interpretability and
relevance of the data, whereas unexplained differences found through independent analyses could
serve as grounds for skepticism about the data. When setting up measures, managers are warned of
the strong effects the process. The applications of various performance measurement systems to
voluntary ACE. From the research perspective, faithfully recording serious adverse events is crucial
to ensuring that all relevant harms are documented. Error reporting to patients was carried out by
those with the strongest safety culture, under 50 years of age and primary care staff. Reproduced
from reference 13, Copyright (2013), with permission from Elsevier View this table: View popup
View inline When comprehensive reporting is not possible (eg, due to space constraints), the
publication should emphasize adverse events of highest clinical relevance given the particular
treatment or study population. The intent of the “clinical relevance” recommendation is to broaden
adverse event reporting beyond what is mandated by regulators and to leverage the clinical
experience and expertise of physician investigators to judge which adverse events should be
highlighted. An institutional review board dilemma: responsible for safety monitoring but not in
control. Delayed in onset, these experiences likely reflect the initial innate immunologic response
followed by a sustained, adaptive response. This guidance is meant to supplement the guidance in
the CONSORT Harms Extension and address issues that have emerged over the past decade.
Clinical risks for development of the acute respiratory distress syndrome. HPV types 16 and 18 have
been implicated in cervical, anal, vaginal, and vulvar cancers, while types 6 and 11 cause anogenital
warts. We therefore provide additional complementary guidance with detailed examples to
encourage more complete and clinically meaningful adverse event reporting. The success or
inadequacy of protocol specified strategies for mitigation of adverse events that are known to be
intervention related (eg, interruption in dosing or dose reduction) should be reported whenever
possible. Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and
18) vaccine in HIV-infected children 7 to 12 years old. Strategies included support organised at the
individual, organisational, national or international levels. This article describes collaboration among
MPIP co-sponsors, industry experts, and journal editors to develop specific recommendations to
improve drug adverse event reporting in industry sponsored, clinical trial publications. Change, The
Challenge for Education and Industry’ (1989), John Heywood applies. Morrison, K (1998).
Management theories for educational change. For example, those adverse events seen with newer
classes of drugs causing chronic, low grade fatigue and other symptoms could be cumulatively
disabling and, therefore, clinically relevant. Multiple requests from the same IP address are counted
as one view. Grade 3 or 4 laboratory abnormalities were uncommon, with low incidences of
aminotransferase increases during the first 12 weeks with daclatasvir plus asunaprevir and placebo in
treatment-naive patients (?2% each).” Reproduced from reference 39, Copyright 2014, with
permission from Elsevier. Understanding the use of balanced scorecard in the context of state owned
ent. Accordingly, the call for more transparent reporting of harms in randomized trials distinguishes
between studies enrolling participants with non-life-threatening conditions (for whom any harm may
be important) and other populations (for whom serious and life-threatening adverse events are the
most important). 15. The aim is to identify the underlying elements required for damage preventing
and ameliorating actions following AEs in order to provide direction for development and future
investigation. Organisational support services perceived as helpful, especially peers, but there were
fears over confidentiality. With 10 evaluation areas and a maximum of 2 points for each area, the
range of the scores for a study varied from 0 to 20 points. For non-interventional or observational
studies, events that are not serious need not be reported. This paper will argue that KPIs for
voluntary ACE must strike the correct balance. Reporting of harms data in RCTs: a systematic review
of empirical assessments against the CONSORT harms extension.
For more common or more serious adverse events, authors should identify previously reported
adverse event profiles and interpret current study findings in the context of what is known about the
drug’s safety. Artificial-Intelligence-in-Marketing-Data.pdf Artificial-Intelligence-in-Marketing-
Data.pdf Tete thermostatique Zigbee MOES BRT-100 V2.pdf Tete thermostatique Zigbee MOES
BRT-100 V2.pdf Bit N Build Poland Bit N Build Poland Bluetooth Low Energy(BLE) and beacons
working Bluetooth Low Energy(BLE) and beacons working Sample literature review 1. The
economic consequences of AEs, and of how the events are handled, are therefore not limited to
healthcare. Next Article in Journal Tailoring EHRs for Specific Working Environments Improves
Work Well-Being of Physicians. Accordingly, the call for more transparent reporting of harms in
randomized trials distinguishes between studies enrolling participants with non-life-threatening
conditions (for whom any harm may be important) and other populations (for whom serious and life-
threatening adverse events are the most important). 15. Performing a systematic review of the
published literature pertaining to an investigational agent can also help investigators to determine
clinical relevance by taking into account previously reported adverse events with that agent. Tracking
adverse events in RCTs: lack of agreement among regulatory institutions. However, research on the
adaptations necessary to fit the requirements of the. Withdrawal of mechanical ventilation in
anticipation of death in the intensive care unit. Sharing clinical trial data: maximizing benefits,
minimizing risk. These are interrelated and can cause significant costs. Report: report on the internet,
New Zealand Federation of Voluntary Welfare. There is a lack of comprehensive models for action
after adverse events. Additional guidance could help authors better identify, communicate, and
display clinically relevant adverse event information in ways that facilitate clinicians’ benefit-risk
assessments for shared treatment decisions with patients. Bernardes C, Carvalho D, Russo P, Saiote
J, Ramos J. Its areas of measurement however, have a strong production orientation that would.
Information about the absence of common adverse events typically seen for a class of drugs can be
equally informative, especially for producing meta-analyses with other trials at a later date.
Following these recommendations and “best practice” examples will help improve the transparency,
clinical relevance, and credibility of adverse event reporting. Table 4 Example of table presenting
confidence intervals with adverse event data (Recommendation 3). 28 This table defines confidence
intervals for the differences between investigational and control patient groups (right hand column).
Authors should also report in the methods section whether adverse events were collected in a non-
elicited (passively collected) or elicited (proactively collected) fashion, adding explicit detail about
the data collection methodology for both types (or refer the reader to the trial protocol if submitted
together with the publication). Liukka, Mari, Alison Steven, M Flores Vizcaya Moreno, Arja M Sara-
aho, Jayden Khakurel, Pauline Pearson, Hannele Turunen, and Susanna Tella. Efficacy of
quadrivalent HPV vaccine against HPV Infection and disease in males. Abiraterone acetate for
treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the
COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study. Tier 3 events should be
reported with descriptive statistics (numbers, percentages, and possibly rates per person time) but
without P values or confidence intervals. The HPV vaccine studies were subsequently marketed as a
novel intervention to curtail the infection’s oncologic aptitude. Systematic literature search process
regarding action after adverse events. We strongly encourage submission of the clinical trial protocol
(inclusive of information pertaining to definitions of adverse events of interest, and methods for
monitoring and data collection) together with the publication, as is already mandated by several
journals. Online discussions were held with other authors to share results and make decisions on next
steps of the process. To provide more specificity, we recommend that abstracts include a phrase or
sentence summarizing the most clinically relevant adverse event data and providing frequency
percentages consistent with those presented in the main text of the publication. On the other hand,
systemic symptoms did not statistically significantly differ.
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-
malignant disorders of the uterine cervix: a placebo-controlled phase II study. Review: anti-CTLA-4
antibody ipilimumab: case studies of clinical response and immune-related adverse events.
Differences between these publications should be flagged proactively in the cover letter to the
editors when submitting the manuscript and disclosed in the publication as appropriate and as agreed
with the editor. Access to the complete adverse event dataset should be made alongside the
publication through data sharing websites or portals that protect participant privacy without placing
undue burdens on requestors. 14 15 Recommendation 2—Report timing, frequency, duration, and
other potentially relevant descriptors when clinically appropriate Other adverse event measurements
can help communicate a more clinically relevant safety profile (box 1). Numerators, denominators,
and percentages are included for all measurements. Please note that many of the page functionalities
won't work as expected without javascript enabled. Put a flag on it. A busy developer's guide to
feature toggles. Brindley, Geoff (2001). Assessment. In R. Carter and D. Nunan (Eds). The.
Moreover, our discussions emphasize that frequency of adverse events alone should not serve as a
proxy for relevance. Ten recommendations for closing the credibility gap in reporting industry-
sponsored clinical research: a joint journal and pharmaceutical industry perspective. As such, none of
the events is definitively related to the study drug. Healthcare professionals reported a pattern of
inadequate social support after adverse event. Graphical approaches to the analysis of safety data
from clinical trials. The emotional responses were: feelings of guilt, anxiety, re-living the event,
tiredness, insomnia and persistent feelings of insecurity. Adverse Event Reporting: Trials and
Tribulations. I. Definitions and Reporting Requirements. The most common AE was injection-site
adverse event, among which pain was the most frequent symptom. Dix etudes impliquaient les
femmes et une les hommes. All articles published by MDPI are made immediately available
worldwide under an open access license. No special. The stage was set for a more balanced style of
evaluation. Although developed for industry sponsored trials, the adoption of our recommendations
would enhance adverse event reporting in clinical research publications regardless of the funding
source and thereby facilitate clinical decision making. Statistical concepts in the planning and
evaluation of drug safety from clinical trials in drug development: issues of international
harmonization. Figures 1-3 ? 17 18 19 and the supplementary appendix 20 21 22 23 provide
examples of additional potentially relevant descriptors. The group engaged in open discussion in an
all-day session that identified key areas for improvement in adverse event reporting and modified the
proposed recommendations in a collaborative fashion. Tropical Medicine and Infectious Disease
(TropicalMed). The reporting of harms in randomized controlled trials of hypertension using the
CONSORT criteria for harm reporting. The research question is: What are the key elements of action
immediately after AEs in HCOs? 2. For example, where appropriate, trials of tumor necrosis factor
(TNF). Boolean search methods were used to retrieve articles related to action after adverse events in
healthcare such follows: “adverse event” AND “disclosure” OR “aftermath”, “adverse event” AND
“professional’ support”, “healthcare” AND “second victim”, “healthcare” AND “after error”. NL
continued to be a paid consultant on the development of the manuscript and management of author
meetings after leaving Navigant. They created corporate missions that had a specific.

You might also like